Literature DB >> 28584053

NLRC3 protein inhibits inflammation by disrupting NALP3 inflammasome assembly via competition with the adaptor protein ASC for pro-caspase-1 binding.

Elif Eren1,2, Mesut Berber1,2, Nesrin Özören3,2.   

Abstract

Inflammasomes are multiprotein complexes that sense pathogen-associated and danger-associated molecular patterns and induce inflammation in cells. The NALP3 inflammasome is tightly regulated by recently discovered control mechanisms, but other modulators still remain to be characterized. NLR family CARD-containing 3 (NLRC3) protein, a caspase recruitment domain (CARD)-containing member of the nucleotide oligomerization domain-like receptor (NLR) family, was found to down-regulate the NF-κB pathway and stimulator of interferon genes (STING)-dependent cytokine secretion. However, the effect of NLRC3 on the NALP3 inflammasome or other inflammasomes is still unknown. We hypothesized that NLRC3 might inhibit NALP3 inflammasome complex assembly. Toward this end, we tested whether NLRC3 overexpression or knockdown influences NALP3 activity in human monocyte and HEK293FT cells when the complex is ectopically reconstituted. We found that NLRC3 indeed decreases NALP3-induced IL-1β maturation and secretion, pro-caspase-1 cleavage, and speck formation by apoptosis-associated speck-like protein containing a CARD (ASC) protein in response to NALP3 activators. We also show that endogenous NLRC3 interacts with both ASC and pro-caspase-1 but not with NALP3, disrupts ASC speck formation through its CARD, and impairs the ASC and pro-caspase-1 interaction. Moreover, the NLRC3 CARD alone could dampen IL-1β secretion and ASC speck formation induced by NALP3 mutants associated with autoinflammatory diseases. In conclusion, we show here that, besides its role in the inhibition of the NF-κB pathway, NLRC3 interferes with the assembly and activity of the NALP3 inflammasome complex by competing with ASC for pro-caspase-1 binding.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  ASC; NLRC3; NLRP3; autoimmune disease; caspase 1 (CASP1); inflammasome; inhibition; pathogen-associated molecular pattern (PAMP); sterile inflammation

Mesh:

Substances:

Year:  2017        PMID: 28584053      PMCID: PMC5535042          DOI: 10.1074/jbc.M116.769695

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response.

Authors:  Alberto Baroja-Mazo; Fatima Martín-Sánchez; Ana I Gomez; Carlos M Martínez; Joaquín Amores-Iniesta; Vincent Compan; Maria Barberà-Cremades; Jordi Yagüe; Estibaliz Ruiz-Ortiz; Jordi Antón; Segundo Buján; Isabelle Couillin; David Brough; Juan I Arostegui; Pablo Pelegrín
Journal:  Nat Immunol       Date:  2014-06-22       Impact factor: 25.606

2.  K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter.

Authors:  Raúl Muñoz-Planillo; Peter Kuffa; Giovanny Martínez-Colón; Brenna L Smith; Thekkelnaycke M Rajendiran; Gabriel Núñez
Journal:  Immunity       Date:  2013-06-27       Impact factor: 31.745

3.  NLRX1 negatively regulates TLR-induced NF-κB signaling by targeting TRAF6 and IKK.

Authors:  Xiaojun Xia; Jun Cui; Helen Y Wang; Liang Zhu; Satoko Matsueda; Qinfu Wang; Xiaoang Yang; Jun Hong; Zhou Songyang; Zhijian J Chen; Rong-Fu Wang
Journal:  Immunity       Date:  2011-06-24       Impact factor: 31.745

4.  A role for mitochondria in NLRP3 inflammasome activation.

Authors:  Rongbin Zhou; Amir S Yazdi; Philippe Menu; Jürg Tschopp
Journal:  Nature       Date:  2010-12-01       Impact factor: 49.962

5.  Overexpressed NLRC3 acts as an anti-inflammatory cytosolic protein.

Authors:  Yetiş Gültekin; Elif Eren; Nesrin Özören
Journal:  J Innate Immun       Date:  2014-09-27       Impact factor: 7.349

6.  Cryopyrin and pyrin activate caspase-1, but not NF-kappaB, via ASC oligomerization.

Authors:  J-W Yu; J Wu; Z Zhang; P Datta; I Ibrahimi; S Taniguchi; J Sagara; T Fernandes-Alnemri; E S Alnemri
Journal:  Cell Death Differ       Date:  2006-02       Impact factor: 15.828

7.  ASC directs NF-kappaB activation by regulating receptor interacting protein-2 (RIP2) caspase-1 interactions.

Authors:  Anasuya Sarkar; Michelle Duncan; Judy Hart; Erin Hertlein; Denis C Guttridge; Mark D Wewers
Journal:  J Immunol       Date:  2006-04-15       Impact factor: 5.422

8.  The CARD plays a critical role in ASC foci formation and inflammasome signalling.

Authors:  Martina Proell; Motti Gerlic; Peter D Mace; John C Reed; Stefan J Riedl
Journal:  Biochem J       Date:  2013-02-01       Impact factor: 3.857

9.  Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist.

Authors:  Hal M Hoffman; Sanna Rosengren; David L Boyle; Jae Y Cho; Jyothi Nayar; James L Mueller; Justin P Anderson; Alan A Wanderer; Gary S Firestein
Journal:  Lancet       Date:  2004 Nov 13-19       Impact factor: 79.321

10.  A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.

Authors:  Rebecca C Coll; Avril A B Robertson; Jae Jin Chae; Sarah C Higgins; Raúl Muñoz-Planillo; Marco C Inserra; Irina Vetter; Lara S Dungan; Brian G Monks; Andrea Stutz; Daniel E Croker; Mark S Butler; Moritz Haneklaus; Caroline E Sutton; Gabriel Núñez; Eicke Latz; Daniel L Kastner; Kingston H G Mills; Seth L Masters; Kate Schroder; Matthew A Cooper; Luke A J O'Neill
Journal:  Nat Med       Date:  2015-02-16       Impact factor: 53.440

View more
  14 in total

1.  Viral DNA Binding to NLRC3, an Inhibitory Nucleic Acid Sensor, Unleashes STING, a Cyclic Dinucleotide Receptor that Activates Type I Interferon.

Authors:  Xin Li; Meng Deng; Alex S Petrucelli; Cheng Zhu; Jinyao Mo; Lu Zhang; Jason W Tam; Pablo Ariel; Baoyu Zhao; Song Zhang; Hengming Ke; Pingwei Li; Nikolay V Dokholyan; Joseph A Duncan; Jenny P-Y Ting
Journal:  Immunity       Date:  2019-03-19       Impact factor: 31.745

Review 2.  Inflammasome activation and regulation: toward a better understanding of complex mechanisms.

Authors:  Danping Zheng; Timur Liwinski; Eran Elinav
Journal:  Cell Discov       Date:  2020-06-09       Impact factor: 10.849

3.  Shifts in the immunoepigenomic landscape of monocytes in response to a diabetes-specific social support intervention: a pilot study among Native Hawaiian adults with diabetes.

Authors:  Christian K Dye; Michael J Corley; Claire Ing; Annette Lum-Jones; Dongmei Li; Marjorie K L M Mau; Alika K Maunakea
Journal:  Clin Epigenetics       Date:  2022-07-18       Impact factor: 7.259

Review 4.  NLRP7: From inflammasome regulation to human disease.

Authors:  Jessica Carriere; Andrea Dorfleutner; Christian Stehlik
Journal:  Immunology       Date:  2021-06-30       Impact factor: 7.215

5.  NLRC3 negatively regulates CD4+ T cells and impacts protective immunity during Mycobacterium tuberculosis infection.

Authors:  Shengfeng Hu; Xialin Du; Yulan Huang; Yuling Fu; Yalong Yang; Xiaoxia Zhan; Wenting He; Qian Wen; Xinying Zhou; Chaoying Zhou; Xiao-Ping Zhong; Jiahui Yang; Wenjing Xiong; Ruining Wang; Yuchi Gao; Li Ma
Journal:  PLoS Pathog       Date:  2018-08-22       Impact factor: 6.823

Review 6.  The Evolving Role of TRAFs in Mediating Inflammatory Responses.

Authors:  Bipandeep Dhillon; Fatemah Aleithan; Zahi Abdul-Sater; Ali A Abdul-Sater
Journal:  Front Immunol       Date:  2019-02-04       Impact factor: 7.561

Review 7.  Inflammasome activation and regulation: toward a better understanding of complex mechanisms.

Authors:  Danping Zheng; Timur Liwinski; Eran Elinav
Journal:  Cell Discov       Date:  2020-06-09       Impact factor: 10.849

8.  Antioral Squamous Cell Carcinoma Effects of Carvacrol via Inhibiting Inflammation, Proliferation, and Migration Related to Nrf2/Keap1 Pathway.

Authors:  Hui Liu; Xiaoliang Xu; Ran Wu; Lei Bi; Chunguang Zhang; Hui Chen; Yang Yang
Journal:  Biomed Res Int       Date:  2021-06-10       Impact factor: 3.411

9.  The NLRP3 inflammasome: a new player in neurological diseases.

Authors:  Elif Eren; Nesrin Özören
Journal:  Turk J Biol       Date:  2019-12-13

Review 10.  The Role of NLRP3 Inflammasome in the Pathogenesis of Traumatic Brain Injury.

Authors:  Natasha Irrera; Massimo Russo; Giovanni Pallio; Alessandra Bitto; Federica Mannino; Letteria Minutoli; Domenica Altavilla; Francesco Squadrito
Journal:  Int J Mol Sci       Date:  2020-08-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.